Conference
A phase II trial of the Src kinase inhibitor AZD0530 in patients with metastatic or locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: A trial of the PMH phase II consortium.
Authors
Mackay H; Au H; McWhirter E; Alcindor T; Jarvi A; MacAlpine K; Wang L; Wright JJ; Oza AM
Volume
28
Pagination
pp. e14544-e14544
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.e14544
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X